A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease
Trial details
- Registry ID
- NCT05956626
- Phase
- Phase 2, Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt DiseaseNCT05956626 | Ocugen | Phase 2, Phase 3 | Active not recruiting | 2026-09-28Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |